tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
CLBS is currently covered by 1 analysts with an average price target of $7.79. This is a potential upside of $7.79 (0%) from yesterday's end of day stock price of $0.
Caladrius Biosciences's activity chart (see below) currently has 3 price targets and 12 ratings on display. The stock rating distribution of CLBS is 100% BUY.
Highest price target for CLBS is $1, Lowest price target is $1, average price target is $7.79.
Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 27-Apr-2022.
Currently out of the existing stock ratings of CLBS, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
1 years 11 months 29 days ago
0/2 (0%)
$13.85 (297.85%)
Buy
2 years 1 months 2 days ago
0/1 (0%)
$9.52 (173.72%)
What is CLBS (Caladrius Biosciences) average time for price targets to be met?
Which analyst has the current highest performing score on CLBS (Caladrius Biosciences) with a proven track record?
Which analyst has the current lower performing score on CLBS (Caladrius Biosciences) with a proven track record?
Which analyst has the most public recommendations on CLBS (Caladrius Biosciences)?
Which analyst is the currently most bullish on CLBS (Caladrius Biosciences)?
Which analyst is the currently most reserved on CLBS (Caladrius Biosciences)?
